FDA Clears MediValve for acWire Guidewire


January 14, 2014
cath lab guidewires heart valve repair medivalve acwire guidewire

MediValve Ltd.'s acWire Guidewire received Pre-Marketing Notification Application (510(k)) from the U.S. Food and Drug Administration (FDA). The acWire is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devices. The acWire may also function as an alignment tool by providing a reference plane of anatomical structure of interest (i.e. the aortic valve). MediValve previously announced clearance of a CE pre-market application for the acWire. The MediValve acWire Guidewire is a single-use, fully disposable medical device utilizing shape-memory alloy technology intended to enable identification of cardiovascular structures utilizing existing imaging methods. Use of acWire employs methods and techniques currently utilized by interventional cardiologists to access the cardiovascular system. Once directed to a selected cardiovascular location, acWire is deformable under fluoroscopy to identify a desired specific anatomical landmark for subsequent therapeutic treatment by the clinician.  AcWire is designed to facilitate the accurate placement and alignment of medical devices in the cardiovascular system during diagnostic and interventional procedures. acWire received CE clearance November 2013. For more information: www.medivalve.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.